Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 9901–9950 of 18658
Jonathan Lock, Senior Vice President, Chief Development Officer is appointed Senior Vice President, Chief Financial Officer, effective June 6, 2023.
On June 5, 2023, the Board appointed Mr. Kraus as permanent Chief Financial Officer (“ CFO ”) of the Company.
the Board of Directors (the “ Board ”) of the Company appointed Diana P. Diaz as interim Chief Financial Officer.
On June 5, 2023, the Company announced that Susan Echard, the Company’s Chief Financial Officer, has separated from the Company, effective immediately.
appointed Gene Jones as the Company’s Interim Chief Financial Officer, effective as of June 1, 2023
replacing Mary Lay Hoitt who left the Company on the same day.
Mr. Anderson’s term as Interim CEO will end at the end of the day on June 25, 2023 and he will remain on the Board.
On June 6, 2023, C.H. Robinson Worldwide, Inc. (the “Company”) announced that its Board of Directors (the “Board”) appointed David P. Bozeman as President and Chief Executive Officer (“CEO”) and a director of the Company, effective June 26, 2023.
On June 1, 2023, AlTi Global, Inc. (the “Company”) announced the resignation of Christine Zhao as Chief Financial Officer of the Company.
The Company also announced that Reid Parmelee, the Company’s Global Controller, has been appointed interim Chief Financial Officer.
Effective as of June 6, 2023, the Company appointed Eliot M. Lurier as its Interim Chief Financial Officer.
On June 5, 2023, SomaLogic, Inc. (the “Company”) and Shaun Blakeman, the Company’s Chief Financial Officer, agreed that Mr. Blakeman will no longer serve as the Company’s Chief Financial Officer.
Effective as of May 31, 2023, Don Smith, the Chief Financial Officer (principal financial and accounting officer) of Tribal Rides International Corp., a Nevada corporation, resigned.
On May 31, 2023, Michael Angel provided formal notice of his resignation as Chief Financial Officer of CXApp Inc.
The Board of Directors of the Company approved, effective as of June 5, 2023, the appointment of Khurram P. Sheikh, the current Chief Executive Officer, as Interim Chief Financial Officer of the Company.
On June 6, 2023, our board of directors appointed Harry Leider, M.D., M.B.A., as Chief Executive Officer and a member of the board of directors
On June 5, 2023, Electromed, Inc. (the "Company") announced the appointment of James L. Cunniff to serve as its next Chief Executive Officer and President, beginning July 1, 2023.
On May 30, 2023, Steve Ward notified the board of directors of Viscogliosi Brothers Acquisition Corp. (the “ Company ”) that he has resigned from his position as Chief Financial Officer the Company, effective June 15, 2023.
In connection with his replacement as Chief Executive Officer, on June 1, 2023, Dr. Dale Pfost agreed to step down from his position on the Board, including in his capacity as Chairman of the Board, effective as of the same date.
appointed Dr. Adi Mor, co-founder of the Company, a current class III member of the Board and the Company's Chief Scientific Officer, as Chief Executive Officer of the Company to replace Dr. Dale Pfost, effective as of the same date.
the Board appointed Ms. Sigal Fattal, the VP of Finance of the Company, as the Chief Financial Officer of the Company to replace Mr. Donald Marvin, effective as of the same date.
the Board appointed Ms. Sigal Fattal, the VP of Finance of the Company, as the Chief Financial Officer of the Company to replace Mr. Donald Marvin, effective as of the same date.
Joy Bruce, the Company’s Director of Accounting, assumed the role of the Company’s principal financial and accounting officer, effective as of such date.
On June 5, 2023, LiveWire Group, Inc. (the “Company”) announced that the Board of Directors appointed Karim Donnez as the Company’s Chief Executive Officer, effective June 12, 2023.
Mr. Clavijo will continue in the role of interim Chief Financial Officer beyond June 9, 2023, pursuant to the terms of a Consulting Agreement entered into by and between the Company and Mr. Clavijo, effective June 10, 2023
On June 1, 2023, the Company announced the appointment of Mr. Neeraj Jain, age 46, as Chief Financial Officer.
On May 30, 2023, Nishit Shah gave notice of his intention to resign from his position as Chief Financial Officer of StarTek, Inc.
Effective as of his appointment as CFO, Mr. Ryan L. Smith, the Chief Executive Officer and director of the Company, ceased serving as Chief Financial Officer and Principal Financial and Accounting Officer of the Company.
On, and effective on, June 1, 2023, the Board of Directors, with the recommendation of the Nominating Committee of the Board of Directors, of U.S. Energy Corp. (the “ Company ”, “ we ” and “ us ”), appointed Mr. Mark Zajac, as the Chief Financial Officer (CFO) and Principal Financial and Accounting Officer of the Company.
On May 30, 2023, Motus GI Holdings, Inc. (the “Company”) received notice of the resignation of Andrew Taylor as the Company’s Chief Financial Officer, and all other positions held at the Company, effective June 2, 2023.
Effective as of June 2, 2023, the Company’s Board of Directors (the “Board”) accepted Mr. Taylor’s resignation as Chief Financial Officer and all other positions held at the Company, and appointed Ravit Ram, 49, as the Company’s Chief Financial Officer.
On May 31, 2023, Scott Scheirman, the Company’s President and Chief Executive Officer, notified the Company of his intent to retire from the Company in order to have more time for family.
On May 31, 2023, Treasure Global Inc (the "Company") received a resignation notice from its Chief Financial Officer, Jaylvin Chan Yee Fei who served as the Company’s principal financial officer and principal accounting officer. Such resignation will be effective on July 31, 2023.
On June 5, 2023, the Company’s Board of Directors appointed Chan Meng Chun, age 51, as the Company’s Chief Financial Officer, effective July 31, 2023
appointed Christopher Meinerz to serve as Chief Financial Officer of the Company.
On June 2, 2023, Filippo “Peter” Caldini provided notice of his resignation as Chief Executive Officer of Acreage Holdings, Inc. (the “Company” or “Acreage”), effective June 30, 2023.
The Board has appointed Dennis Curran, the Company’s current Chief Operating Officer, as the Chief Executive Officer of Acreage, effective July 1, 2023.
David Hayes has been appointed as Chief Financial Officer of the Company, effective June 26, 2023
As previously announced, Dr. Torsten Hombeck will begin his service as the Company’s Chief Financial Officer on June 15, 2023.
Effective May 31, 2023, Marlene McLennan’s term as Interim Chief Financial Officer of Aspira Women’s Health Inc. (the “Company”) has come to a close, pursuant to her Employment Agreement with the Company.
On May 30, 2023, Scott Praill resigned from his position as Chief Financial Officer of Kintara Therapeutics, Inc. (the “Company”), effective May 31, 2023.
On June 1, 2023, the Company’s Board of Directors (the “Board”) appointed Robert E. Hoffman, the current President, Chief Executive Officer, and Chairman of the Board of the Company, to succeed Mr. Praill as the Company’s interim Chief Financial Officer.
Eric Johnson has been appointed as CEO of the Company effective June 1, 2023.
Effective June 1, 2023, Alexander Lurie is stepping down as the Company’s Chief Executive Officer (“CEO”) and Priyanka Carr is stepping down as the Company’s Chief Operating Officer (“COO”).
Brian Piekos 48 Chief Financial Officer
(ii) each of Gregory S. Curhan, Angion’s Chief Financial Officer and Jay R. Venkatesan, M.D., were terminated as employees of the Company effective as of the effective time of the Merger.
Robert Connelly 63 Chief Executive Officer, President and Class I Director
Mr. McKim succeeds Karl F. Krebs who will retire as Chief Financial Officer and Treasurer of the Corporation, and Executive Vice President, Chief Financial Officer and Treasurer of the Bank effective June 30, 2023.
appointed Dale M. McKim III, age 48, Chief Financial Officer and Treasurer of the Corporation, and Executive Vice President, Chief Financial Officer and Treasurer of the Bank effective July 1, 2023.
On May 31, 2023, the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) appointed David M. Urso to be President and Chief Executive Officer (“CEO”) of the Company, effective as of June 2, 2023
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.